Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Hepatitis C

Interventions

DRUG

Direct acting anti-viral agents

Standard of care for Hepatitis C treatment

Trial Locations (2)

Soroka UMC, Beersheba

Rabin Medical Center, Petah Tikva

All Listed Sponsors

collaborator

Loyola University, Harel Dahari, PhD, mathematical modeling support

UNKNOWN

lead

Soroka University Medical Center

OTHER

NCT03603327 - Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection | Biotech Hunter | Biotech Hunter